The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Against which human papillomavirus types shall we vaccinate and screen? the international perspective
Open accessAbstract
At least 15 types of HPV have been associated with cervical cancer, but current HPV vaccines confer only type‐specific immunity. To determine geographic variations in the HPV type distribution in cervical cancer, we carried out a pooled analysis of data from an international survey of HPV types in cervical cancer and from a multicenter case‐control study, both co‐coordinated by the IARC. Study cases were 3,607 women with incident, histologically confirmed cervical cancer recruited in 25 countries. HPV DNA detection and typing in cervical cells or biopsies were centrally done using PCR assays. Estimates of the potential number of cases prevented by HPV type‐specific vaccines and changes in the validity of different HPV screening cocktails were calculated. HPV DNA was detected in 96% of specimens, and 30 different types were detected. The 15 most common types were, in descending order of frequency, 16, 18, 45, 31, 33, 52, 58, 35, 59, 56, 39, 51, 73, 68 and 66. Higher than average proportions of type 16 were found in northern Africa, of type 18 in south Asia, of type 45 in sub‐Saharan Africa and of type 31 in Central/South America. A vaccine including types 16 and 18 could potentially prevent 71% of cervical cancers worldwide, but its impact with regard to the percentage of cases potentially prevented would be higher in Asia and Europe/North America. In contrast, a vaccine containing the 7 most common HPV types would prevent about 87% of cervical cancers worldwide, with little regional variation. The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Self-citationCancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Self-citationPrevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Self-citationA Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Self-citationde Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C., Meijer, C. J. L. M., & Snijders, P. J. F. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-4-1057 · Cited by 1,283
Self-citationHarro, C. D., Pang, Y.-Y. S., Roden, R. B. S., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.284 · Cited by 607
Munoz, N., Bosch, F. X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Martos, C., Ascunce, N., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520513 · Cited by 568
Self-citationPCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems
Qu, W., Jiang, G., Cruz, Y., Chang, C. J., Ho, G. Y., Klein, R. S., & Burk, R. D. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1304-1310.1997 · Cited by 463
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728
Self-citationSmith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22527 · Cited by 1,686
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
Chapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Self-citationWorldwide burden of cervical cancer in 2008
Arbyn, M., Castellsagué, X., de Sanjosé, S., Bruni, L., Saraiya, M., Bray, F., & Ferlay, J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr015 · Cited by 1,130
Self-citationClifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Self-citationMolecular biology of human papillomavirus infection and cervical cancer
Doorbar, J. (2006) · Clinical Science · doi:10.1042/cs20050369 · Cited by 1,072
Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,066
Nooraei, S., Bahrulolum, H., Hoseini, Z. S., Katalani, C., Hajizade, A., Easton, A. J., & Ahmadian, G. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00806-7 · Cited by 869
Bosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Self-citationArbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 760
Meijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692
Self-citationCastellsagué, X., Díaz, M., de Sanjosé, S., Muñoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J. F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj067 · Cited by 688
Self-citationArbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009069.pub3 · Cited by 621
Natural history and epidemiology of HPV infection and cervical cancer
Castellsagué, X. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.07.045 · Cited by 590
Self-citationChapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
Clifford, G., Franceschi, S., Diaz, M., Muñoz, N., & Villa, L. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.026 · Cited by 568
Self-citationHuman Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
Egawa, N., Egawa, K., Griffin, H., & Doorbar, J. (2015) · Viruses · doi:10.3390/v7072802 · Cited by 553
GIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Mitra, A., MacIntyre, D. A., Marchesi, J. R., Lee, Y. S., Bennett, P. R., & Kyrgiou, M. (2016) · Microbiome · doi:10.1186/s40168-016-0203-0 · Cited by 484
HPV‐mediated cervical carcinogenesis: concepts and clinical implications
Snijders, P. J., Steenbergen, R. D., Heideman, D. A., & Meijer, C. J. (2006) · The Journal of Pathology · doi:10.1002/path.1866 · Cited by 455
Self-citationProphylactic human papillomavirus vaccines
Lowy, D. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28607 · Cited by 428
Syrjänen, S., Lodi, G., von Bültzingslöwen, I., Aliko, A., Arduino, P., Campisi, G., Challacombe, S., Ficarra, G., Flaitz, C., Zhou, H., et al. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01792.x · Cited by 378
Human papillomavirus and HPV vaccines: a review
Cutts, F. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038414 · Cited by 370
The Epidemiology of Human Papillomavirus Infection and Cervical Cancer
Bosch, F. X., & de Sanjosé, S. (2007) · Disease Markers · doi:10.1155/2007/914823 · Cited by 357
Self-citationWei, F., Georges, D., Man, I., Baussano, I., & Clifford, G. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01097-3 · Cited by 317
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Serrano, B., Alemany, L., Tous, S., Bruni, L., Clifford, G. M., Weiss, T., Bosch, F. X., & de Sanjosé, S. (2012) · Infectious Agents and Cancer · doi:10.1186/1750-9378-7-38 · Cited by 301
Self-citationEducational interventions to increase HPV vaccination acceptance: A systematic review
Fu, L. Y., Bonhomme, L.-A., Cooper, S. C., Joseph, J. G., & Zimet, G. D. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.091 · Cited by 298
Shrestha, A. D., Neupane, D., Vedsted, P., & Kallestrup, P. (2018) · PubMed · doi:10.22034/apjcp.2018.19.2.319 · Cited by 295
Auvert, B., Sobngwi-Tambekou, J., Cutler, E., Nieuwoudt, M., Lissouba, P., Puren, A., & Taljaard, D. (2009) · Journal of Infectious Diseases · doi:10.1086/595566 · Cited by 285
How will HPV vaccines affect cervical cancer?
Roden, R., & Wu, T.-C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1973 · Cited by 283
Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses
Bagarazzi, M. L., Yan, J., Morrow, M. P., Shen, X., Parker, R. L., Lee, J. C., Giffear, M., Pankhong, P., Khan, A. S., Broderick, K. E., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004414 · Cited by 282
Insinga, R. P., Liaw, K.-L., Johnson, L. G., & Madeleine, M. M. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2922 · Cited by 267
Human papillomavirus infection: biology, epidemiology, and prevention
SCHEURER, M. E., TORTOLERO-LUNA, G., & ADLER-STORTHZ, K. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00246.x · Cited by 260
Di Mario, S., Basevi, V., Lopalco, P. L., Balduzzi, S., D’Amico, R., & Magrini, N. (2015) · Journal of Immunology Research · doi:10.1155/2015/435141 · Cited by 257
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Goldie, S. J., O'Shea, M., Campos, N. G., Diaz, M., Sweet, S., & Kim, S.-Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.053 · Cited by 197
Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases
Trottier, H., & Burchell, A. N. (2009) · Public Health Genomics · doi:10.1159/000214920 · Cited by 156
Sowjanya, A. P., Jain, M., Poli, U. R., Padma, S., Das, M., Shah, K. V., Rao, B., Devi, R. R., Gravitt, P. E., & Ramakrishna, G. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-116 · Cited by 155
Self-citationYu, Y., Xu, M., Sun, J., Li, R., Li, M., Wang, J., Zhang, D., & Xu, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146741 · Cited by 94
Petäjä, T., Pedersen, C., Poder, A., Strauss, G., Catteau, G., Thomas, F., Lehtinen, M., & Descamps, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.25887 · Cited by 91
(2009) · PubMed · Cited by 70
Baloch, Z., Li, Y., Yuan, T., Feng, Y., Liu, Y., Tai, W., Liu, L., Wang, B., Zhang, A.-M., Wu, X., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1562-7 · Cited by 42
Latsuzbaia, A., Tapp, J., Nguyen, T., Fischer, M., Arbyn, M., Weyers, S., & Mossong, J. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.04.011 · Cited by 27
Nassereddine, H., Charpentier, C., Bucau, M., Joly, V, Bienvenu, L., Davitian, C., Abramowitz, L., Benabderrahmane, D., Kotelevets, L., Chastre, E., et al. (2018) · HIV Medicine · doi:10.1111/hiv.12661 · Cited by 6
Metadata
- Authors
- Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2004-04-12
- Volume
- 111
- Issue
- 2
- Pages
- 278-285
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2139349670
- Cited by
- 1,104
- References
- 23
- FWCI
- 40.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.